nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cardiac magnetic resonance-derived right atrial functional analysis in patients with atrial fibrillation and typical atrial flutter
|
Gucuk Ipek, Esra |
|
|
59 |
2 |
p. 381-391 |
artikel |
2 |
Cardioinhibitory syncope: from pathophysiology to treatment—should we think on cardioneuroablation?
|
Garcia, Alan |
|
|
59 |
2 |
p. 441-461 |
artikel |
3 |
Clinical and electrophysiological characteristics predicting the re-ablation outcome for atrial fibrillation patients
|
Miao, Changqing |
|
|
59 |
2 |
p. 373-379 |
artikel |
4 |
COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies
|
Gopinathannair, Rakesh |
|
|
59 |
2 |
p. 329-336 |
artikel |
5 |
COVID-19 and electrophysiology procedures—review, reset, reboot!!!
|
Pothineni, Naga Venkata K. |
|
|
59 |
2 |
p. 303-305 |
artikel |
6 |
Esophageal cooling for protection during left atrial ablation: a systematic review and meta-analysis
|
Leung, Lisa WM |
|
|
59 |
2 |
p. 347-355 |
artikel |
7 |
His bundle pacing for cardiac resynchronization therapy: a systematic literature review and meta-analysis
|
Qi, Jinlei |
|
|
59 |
2 |
p. 463-470 |
artikel |
8 |
“If at first you don’t succeed”: repeat ablations in young patients with supraventricular tachycardia
|
Rochelson, Ellis |
|
|
59 |
2 |
p. 423-429 |
artikel |
9 |
Pulmonary vein atrial tachycardia: do we really need to isolate or freeze?
|
O’Shea, Catherine |
|
|
59 |
2 |
p. 299-301 |
artikel |
10 |
QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin
|
Hsia, Brian C |
|
|
59 |
2 |
p. 337-345 |
artikel |
11 |
Rationale and design of a randomized clinical trial to compare two antithrombotic strategies after left atrial appendage occlusion: double antiplatelet therapy vs. apixaban (ADALA study)
|
Flores-Umanzor, Eduardo Josué |
|
|
59 |
2 |
p. 471-477 |
artikel |
12 |
Recommendations for the measurement of the QT interval during the use of drugs for COVID-19 infection treatment. Updatable in accordance with the availability of new evidence
|
Asensio, Enrique |
|
|
59 |
2 |
p. 315-320 |
artikel |
13 |
Recommendations for the organization of electrophysiology and cardiac pacing services during the COVID-19 pandemic
|
Saenz, Luis C. |
|
|
59 |
2 |
p. 307-313 |
artikel |
14 |
Serum tenascin-C levels in atrium predict atrial structural remodeling processes in patients with atrial fibrillation
|
Shiomi, Yuichiro |
|
|
59 |
2 |
p. 401-406 |
artikel |
15 |
Severe and uniform bi-atrial remodeling measured by dominant frequency analysis in persistent atrial fibrillation unresponsive to ablation
|
Luca, Adrian |
|
|
59 |
2 |
p. 431-440 |
artikel |
16 |
Temperature drop in thawing phase reflects sufficient ice formation and better outcome of pulmonary vein isolation using second-generation cryoballoon
|
Kaneshiro, Takashi |
|
|
59 |
2 |
p. 357-364 |
artikel |
17 |
The COVID-19 challenge to cardiac electrophysiologists: optimizing resources at a referral center
|
Mazzone, Patrizio |
|
|
59 |
2 |
p. 321-327 |
artikel |
18 |
The efficacy of combination of transcatheter atrial septal defects closure and radiofrequency catheter ablation for the prevention of atrial fibrillation recurrence through bi-atrial reverse remodeling
|
Kamioka, Masashi |
|
|
59 |
2 |
p. 365-372 |
artikel |
19 |
Ultrasound guidance for femoral venous access in electrophysiology procedures—systematic review and meta-analysis
|
Kupó, Péter |
|
|
59 |
2 |
p. 407-414 |
artikel |
20 |
Ventriculoatrial conduction in patients without high-grade AV block: when is it present?
|
Elayi, Claude S. |
|
|
59 |
2 |
p. 393-400 |
artikel |
21 |
WATCHMAN implantation in patients with a history of atrial fibrillation and intracranial hemorrhage
|
Hucker, William J. |
|
|
59 |
2 |
p. 415-421 |
artikel |